For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Aldeyra Therapeutics Inc (NASDAQ: ALDX) was $2.32 for the day, up 3.57% from the previous closing price of $2.24. In other words, the price has increased by $3.57 from its previous closing price. On the day, 1.12 million shares were traded. ALDX stock price reached its highest trading level at $2.4 during the session, while it also had its lowest trading level at $2.25.
Ratios:
Our analysis of ALDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Machatha Stephen sold 16,041 shares of ALDX for $75,975 on Aug 12 ’24. The Chief Development Officer now owns 236,771 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the insider of the company, sold 10,834 shares for $4.74 each. As a result, the insider received 51,313 and left with 126,382 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 138524176 and an Enterprise Value of 52675808.
Stock Price History:
The Beta on a monthly basis for ALDX is 1.21, which has changed by -0.4111675 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -55.71%, while the 200-Day Moving Average is calculated to be -54.27%.
Shares Statistics:
ALDX traded an average of 1.49M shares per day over the past three months and 1975440 shares per day over the past ten days. A total of 59.65M shares are outstanding, with a floating share count of 57.98M. Insiders hold about 2.90% of the company’s shares, while institutions hold 55.53% stake in the company. Shares short for ALDX as of 1743379200 were 3549304 with a Short Ratio of 2.38, compared to 1740700800 on 3614145. Therefore, it implies a Short% of Shares Outstanding of 3549304 and a Short% of Float of 7.1499999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Aldeyra Therapeutics Inc (ALDX) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.2 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.69 and -$1.32 for the fiscal current year, implying an average EPS of -$0.96. EPS for the following year is $0.29, with 4.0 analysts recommending between $1.52 and -$0.53.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $76.03M in the next fiscal year. The high estimate is $160M and the low estimate is $13M.
